CDC Booster Support A US Centers for Disease Control and Prevention advisory committee has indicated its support for booster doses of SARS-CoV-2 vaccines, according to the Wall Street Journal. CDC's Slow Sharing Critics tell the Washington Post that the US Centers for Disease Control and Prevention has been too slow to release needed data on Delta SARS-CoV-2 variant. Boosters for the US NPR reports that US adults who received either the Pfizer-BioNTech or Moderna SARS-CoV-2 vaccines will be eligible for a booster shot. Delta's Reach in the US The Centers for Disease Control and Prevention says the Delta variant accounts for 83 percent of all sequenced COVID-19 cases in the US, according to CNBC. Another Dose for Immunocompromised Considered The Washington Post reports that a US advisory panel is to consider whether the data supports an additional vaccine dose for immunocompromised individuals. Mar 16, 2021 Fulgent Genetics, Aegis Sciences Win CDC Contracts for SARS-CoV-2 Surveillance Feb 24, 2021 LexaGene Open-Access Syndromic Panel Platform Lets Labs Customize Targets, Including SARS-CoV-2 Premium Feb 17, 2021 Biden Administration Will Provide $1.6B to Improve COVID-19 Testing and Sequencing Feb 4, 2021 NYC to Fund Coronavirus Surveillance Sequencing as Congress Proposes $2B for Nationwide Program Jan 19, 2021 Quest Diagnostics Wins CDC Contract to Sequence SARS-CoV-2 Samples Jan 5, 2021 Illumina, Helix Collaborate on CDC-Coordinated Coronavirus Surveillance Dec 28, 2020 President Trump Signs FY 2021 Spending Bill to Boost NIH Budget 3 Percent Dec 22, 2020 Congress Approves 3 Percent Increase in NIH Budget for Fiscal 2021 Dec 4, 2020 FDA Authorizes Use of Pooled Samples With CDC Coronavirus Test Dec 2, 2020 CDC Advises Avoiding Holiday Travel, Using SARS-CoV-2 Testing to Mitigate Risk During COVID-19 Surge Nov 30, 2020 AquaVitas Partners With HHS, CDC on Wastewater Coronavirus Study Oct 12, 2020 Africa Pathogen Genomics Initiative Launches With $100M Investment Sep 11, 2020 NIST Creating Reference Material for SARS-CoV-2 Diagnostic Assay Developers Premium Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Jul 14, 2020 House Committee Votes for $5.5B Boost to NIH Budget Jul 3, 2020 CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization Jun 16, 2020 Roche, SpeeDx Partner to Expand Access to Antibiotic Resistance Tests Jun 4, 2020 CDC Develops Test for Simultaneous Detection of COVID-19, Flu May 20, 2020 Q&A: Dartmouth's Gregory Tsongalis on Implementing Molecular SARS-CoV-2 Tests in the Lab Premium May 1, 2020 CDC Leads Public-Private Consortium to Coordinate SARS-CoV-2 Genome Sequencing in US Load More Breaking News GenXys, Helix Partner to Provide Clinical Decision Support for PGx Testing Persephone Biosciences, Janssen Biotech Ink Biomarker Discovery Agreement Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy PhenoTips Raises C$2.5M in Seed Funding Fauna Bio Raises $9M in Seed Money Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test The Scan Two J&J Doses Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports. Pfizer-BioNTech Vaccine Response in Kids The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post. Chicken Changes to Prevent Disease The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics. PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.